These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10607220)

  • 1. Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
    Shaw T; Locarnini SA
    J Viral Hepat; 1999 Mar; 6(2):89-106. PubMed ID: 10607220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.
    Mutimer D; Pillay D; Cook P; Ratcliffe D; O'Donnell K; Dowling D; Shaw J; Elias E; Cane PA
    J Infect Dis; 2000 Feb; 181(2):713-6. PubMed ID: 10669360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain.
    León P; Pozo F; Echevarría JM
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):133-7. PubMed ID: 14987532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.
    Delaney WE; Edwards R; Colledge D; Shaw T; Torresi J; Miller TG; Isom HC; Bock CT; Manns MP; Trautwein C; Locarnini S
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1705-13. PubMed ID: 11353615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
    Papatheodoridis GV; Dimou E; Papadimitropoulos V
    Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
    de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
    J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of combination therapy with lamivudine and famciclovir following lamivudine monotherapy for hepatitis B virus infection in patients coinfected with human immunodeficiency virus-1.
    Matthews GV; Pillay D; Cane P; Ratcliffe D; Gazzard B; Nelson M
    Clin Infect Dis; 2001 Dec; 33(12):2049-54. PubMed ID: 11698987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of famciclovir and lamivudine in the long-term treatment of hepatitis B infection after liver transplantation.
    Rayes N; Seehofer D; Hopf U; Neuhaus R; Naumann U; Bechstein WO; Neuhaus P
    Transplantation; 2001 Jan; 71(1):96-101. PubMed ID: 11211203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives for the treatment of hepatitis B virus infections.
    De Clercq E
    Int J Antimicrob Agents; 1999 Jul; 12(2):81-95. PubMed ID: 10418752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
    Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
    J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
    Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
    J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
    Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
    Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of famciclovir in the treatment of lamivudine resistance related to an atypical hepatitis B virus mutant.
    Tang S; Ho SK; Moniri K; Lai KN; Chan TM
    Transplantation; 2002 Jan; 73(1):148-51. PubMed ID: 11792996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with lamivudine against hepatitis B virus.
    Jaeckel E; Manns MP
    Intervirology; 1997; 40(5-6):322-36. PubMed ID: 9675637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance.
    Pichoud C; Seignères B; Wang Z; Trépo C; Zoulim F
    Hepatology; 1999 Jan; 29(1):230-7. PubMed ID: 9862871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroconversion after the addition of famciclovir therapy in a child with hepatitis B virus infection after liver transplantation who developed lamivudine resistance.
    Shapira R; Daudi N; Klein A; Shouval D; Mor E; Tur-Kaspa R; Dinari G; Ben-Ari Z
    Transplantation; 2002 Mar; 73(5):820-2. PubMed ID: 11907436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.
    Wolters LM; Hansen BE; Niesters HG; de Man RA
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1007-11. PubMed ID: 12352221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study.
    Krüger M; Tillmann HL; Trautwein C; Bode U; Oldhafer K; Maschek H; Böker KH; Broelsch CE; Pichlmayr R; Manns MP
    Liver Transpl Surg; 1996 Jul; 2(4):253-62. PubMed ID: 9346658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure.
    Günther S; von Breunig F; Santantonio T; Jung MC; Gaeta GB; Fischer L; Sterneck M; Will H
    J Hepatol; 1999 May; 30(5):749-54. PubMed ID: 10365797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.